Burden of Influenza at Emergency Department Level : BIED
NCT ID: NCT04153331
Last Updated: 2025-09-04
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
2487 participants
INTERVENTIONAL
2020-01-13
2020-03-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Increasing the investigator's knowledge of the impact of influenza on the hospital system, particularly on emergencies, which are the most affected service, is essential to better adapt the resources put in place to care for patients.
The study will allow a better understanding of the influenza burden, by systematically documenting the severe events (i.e. requiring consultations to the Emergency Rooms) that are triggered by influenza but not necessarily reported/recorded as influenza.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Retrospective Observational Study on the Epidemiological Characteristics of Influenza Patients
NCT04110990
Burden of Influenza at Emergency Department (ED) Level in European Countries
NCT04244500
Clinical Trial to Assess the Influenza Vaccination of the Hospitalized Adults
NCT02027233
Incidence of H1N1v Influenza-like Illness and Risk Factors for Serious Influenza Forms in HIV Infected Patients
NCT01039220
Epidemiology and Clinical Presentation of H1N1 Infection in Children in Geneva
NCT01022931
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NA
SINGLE_GROUP
OTHER
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients admitted to emergency department with medical cause
Patient included in emergency with a nasal swab
Nasal swab
Patient included in emergency with a nasal swab
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nasal swab
Patient included in emergency with a nasal swab
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Consultation for a medical cause
Exclusion Criteria
* Pregnant, parturient and lactating women
* Persons deprived of their liberty
* Persons of full age who are subject to a legal protection measure
* Persons not affiliated to a social security system
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Hospices Civils de Lyon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Philppe VANHEMS, MD
Role: PRINCIPAL_INVESTIGATOR
Service Hygiène, Epidémiologie et Prévention
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Service Hygiène, Epidémiologie et Prévention
Lyon, , France
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Amour S, Rubio AP, Orsi A, Oppert M, Loebermann M, Del Pozo Vegas C, Tazarourte K, Douplat M, Jacquin L, Icardi G, Walker J, Glass A, Nealon J, Chaves SS; FERS Study Group; Bricout H, Vanhems P. Influenza in Adults Seeking Care at Seven European Emergency Departments: A Prospective Active Surveillance During the 2019-2020 Influenza Season. Influenza Other Respir Viruses. 2024 Nov;18(11):e70040. doi: 10.1111/irv.70040.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
69HCL19_0755
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.